Drug profile · INN
pemetrexed ditromethamine
PEMETREXED DITROMETHAMINE
pemetrexed ditromethamine (PEMETREXED DITROMETHAMINE) is a dihydrofolate reductase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — pemetrexed ditromethamine
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pemetrexed ditromethamine (PEMETREXED DITROMETHAMINE) is a dihydrofolate reductase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Dihydrofolate reductase inhibitor
Primary target: Dihydrofolate reductase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pemetrexed ditromethamine?
pemetrexed ditromethamine (PEMETREXED DITROMETHAMINE) is a dihydrofolate reductase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for pemetrexed ditromethamine?
PEMETREXED DITROMETHAMINE is a marketed brand name for pemetrexed ditromethamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pemetrexed ditromethamine?
pemetrexed ditromethamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.